Petros Pharmaceuticals, Inc. (PTPI) Company Sales Revenue

Symbol and logo of brand Petros Pharmaceuticals, Inc. (PTPI)

The current R&D pipeline of Petros Pharmaceuticals (PTPI) is limited to updating digital services and expanding access to medications. The company's sales on this chart demonstrate the result of such a strategy, where the 0.01 mark serves as the current indicator. Revenue growth is based on aggressive sales representative KPIs and bonuses for pharmacy distribution, as well as the optimization of confidential prescription drug delivery via online channels.

PTPI (Petros Pharmaceuticals, Inc.) Revenue and Sales Volume history from 07/04/2022 to 06/28/2025

Analytical breakdowns for Petros Pharmaceuticals

- market price and analyst price targets:
- market capitalization details:
Comprehensive company analysis:PTPI (petrospharma.com)
Finished products of Petros Pharmaceuticals Inc

This indicator captures daily revenue dynamics, allowing for the filtering of market noise to identify the fundamental growth vector of the business amid changing capital costs. An analysis of the sales chronology for Petros Pharmaceuticals (PTPI) demonstrates a lack of operating leverage, as revenue growth is offset by a linear increase in traffic acquisition costs and the high expense of online marketing for men's pharmaceuticals.

Analysis of competing companies

HLN: Company Sales Revenue|Company Revenue Kenvue (KVUE)|VRNA (Verona Pharma Corp) - Company Sales Revenue|Company Revenue Jyong Biotech MENS|Ligand Pharma - Company Revenue|AMRX - Company Revenue|Company Total Revenue perrigo.com|ALVO (Alvotech SA) - Company Sales|Company Total Sales Volume Liquidia Technologies LQDA|GLPG (Galapagos N.V.) - Revenue and Sales Volume|ANIP: Company Sales Revenue|Company Revenue Afrezza (MNKD)|Revenue and Sales Volume amphastar.com (AMPH)|Revenue and Sales Volume PCRX (pacira.com)|Company Sales Revenue SPRY|Theravance Biopharma Inc - Revenue and Sales Volume|Company Gross Revenue Aquestive Therapeutics AQST|SCPH: Revenue and Sales Volume|Company Sales Tectonic Therapeutic, Inc.|TNXP (tonixpharma.com) - Revenue and Sales Volume|SXTC (China SXT Pharmaceuticals, Inc.) - Company Total Sales|Company Revenue eupraxiapharma.com (EPRX)|Company Total Sales BHST|Company Revenue eXoZymes EXOZ|Company Sales Revenue ORMP|ENTX - Company Revenue|HYFT: Company Revenue|ABVC BioPharma, Inc (ABVC) - Company Revenue|Cumberland Pharma - Company Sales Revenue|QNTM (Quantum BioPharma Corp) - Revenue and Sales Volume|FibroGen, Inc. - Company Annual Revenue|Revenue and Sales Volume TELO|Company Gross Revenue Rani Therapeutics Holdings, Inc.|Company Revenue Synergy CHC Corp. SNYR|Revenue and Sales Volume rallybio.com RLYB|Lexaria Bioscience Corp. - Revenue and Sales Volume|PULM: Company Revenue|PTHL (ftzy.com.cn) - Company Sales|APM: Company Total Sales|LYRA (Lyra Therapeutics Inc) - Revenue and Sales Volume|Company Sales Volume IBO (Impact BioMedical)|Company Sales TNFA (TNF Pharmaceuticals)|Revenue and Sales Volume cbdMD Corp (YCBD)|Revenue and Sales Volume PRFX (PainReform)|Company Gross Revenue Auris Medical (CYTO)|LIPO - Company Revenue|Optinose (OPTN) - Company Sales|Pieris (PIRS) - Company Revenue|Company Annual Revenue PROC (Procaps Group S.A.)|QLI (Qilian International Holding) - Revenue and Sales Volume|SLRN: Company Sales Revenue|Revenue and Sales Volume TFFP